Benefits


GlucoRx Allpresan® Foam Creams
The Most Significant Advantages

n1

Patented Actively Breathable Formula

GlucoRx Allpresan® foam creams repair and strengthen the damaged skin barrier thus protecting against skin infections and ulcerations making them ideal for application between the toes1,6,7.

They reduce roughness and smooth the skin, counteract pressure marks and protect against abrasion.6,7

1


n2

Rapidly Absorbed Without Greasiness

GlucoRx Allpresan® foam creams absorb rapidly and completely without leaving behind an unpleasant greasy film. No occluding cream layer is formed on the skin surface. Tights and socks, even compression stockings, can be worn instantly.The daily routine is not restricted.2,5

2


n3

Optimum Skin Tolerance

GlucoRx Allpresan® foam creams are so gentle in application that they are suitable for sensitive skins and are tested and recommended by the DAAB (German allergy & Asthma Association). There are no artificial fragrances, colourants or preservatives added.

3


n4

Evenly Distributed

GlucoRx Allpresan® foam creams spread very effectively and evenly compared to conventional creams, without occluding the skin or leaving any residue, ensuring full even skin coverage and making them ideal for use between the toes.
Conventional creams are not recommended to be used between the toes as they are not evenly spread and cream residues can build up. The skin becomes too moist which can lead to bacterial infections.1

4


n5

Lasts Up To Twice As Long

GlucoRx Allpresan® foam creams have a 10-fold increase in volume and are up to twice as efficient as conventional creams and ointments, which in turn create much lower daily treatment costs.1,4


n6

Preferred Formulation

GlucoRx Allpresan® foam creams are preferred by 80% of patients over conventional creams and ointments.3

6



References

1. Prof. Rolf Daniels, PhD – University of Tublingen, Spraul M, Alpelqvist J. Skin and Foot – Medical Skin Care of Patients with Diabetic Foot Syndrome. Thieme Praxis Report 2013;5(11): 12-14
2. Prof. Ehrhardt Proksch, MD,PhD – University of Kiel, Spraul M, Alpelqvist J. Skin and Foot – Medical Skin Care of Patients with Diabetic Foot Syndrome. Thieme Praxis Report 2013;5(11): 12-14
3. W. Wigger-Alberti, MD, Recognised Dermatological Institute – Unpublished study 2011
4. Prof. Dr Med. H Tronnier, Prof. Dr. Ulrike Heinrich – Definition of the Quantity applied of both products – Unpublished study 2009
5. Prof. Thomas Haak, MD, PhD – Diabetes Center Mergentheim, Spraul M, Alpelqvist J. Skin and Foot – Medical Skin Care of Patients with Diabetic Foot Syndrome. Thieme Praxis Report 2013;5(11): 9-11
6. Podologie Nr. 1 March 2005
7. Prof. Erhardt Proksch, Urea – Not a harmful Substance